SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-21-026300
Filing Date
2021-10-26
Accepted
2021-10-26 10:42:49
Documents
12
Period of Report
2021-10-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 40239
  Complete submission text file 0001493152-21-026300.txt   213365

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sigy-20211020.xsd EX-101.SCH 3052
3 XBRL LABEL FILE sigy-20211020_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE sigy-20211020_pre.xml EX-101.PRE 22377
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3996
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-55575 | Film No.: 211346783
SIC: 3841 Surgical & Medical Instruments & Apparatus